Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02076022 · ClinicalTrials.gov registry record · NA
AMP30: Autologous Fat Grafting, Amputation Sites Pain: Randomized
A NA study of Amputation and Wounded Warrior, sponsored by J. Peter Rubin, MD.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT02076022: Completed NA study of Amputation and Wounded Warrior, sponsored by J. Peter Rubin, MD.
NCT02076022 is a NA study of Amputation and Wounded Warrior that has completed, run by J. Peter Rubin, MD. The registered enrollment target is 10 participants, below the 133-participant average among 65 other Amputation trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02076022, a NA study of Amputation and Wounded Warrior, has completed, sponsored by J. Peter Rubin, MD.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
We propose a prospective, randomized clinical study to assess the efficacy of minimally invasive autologous fat transfer addressing pain and poor prosthetic fit at amputation sites.
Primary Outcome
Assess the efficacy of minimally invasive autologous fat transfer at the amputation sites and the modulation of pain at the respective sites Compare two minimally invasive techniques as an alternative to invasive operations, with the understanding that this therapy does not preclude more invasive procedures in the future. We further hypothesize that enriching the fat graft with autologous adipose stromal cells utilizing the Tissue Genesis Cell Isolation System (CIS), a regenerative medicine app
Conditions Studied
Interventions
- DEVICE Enhanced Fat Grafting
- PROCEDURE Standard fat graft
Study Locations (1)
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2014-04-08 |
| Est. Completion | 2019-01-28 |
| Phase | NA |
What the finished NCT02076022 record still lists
NCT02076022 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 133-participant average among 65 other Amputation trials with a reported enrollment target (92% lower).
The record links to 3 conditions, with Amputation appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Fat Grafting is the first listed.
NCT02076022 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02076022 about?
NCT02076022 is a clinical study titled "AMP30: Autologous Fat Grafting, Amputation Sites Pain: Randomized". We propose a prospective, randomized clinical study to assess the efficacy of minimally invasive autologous fat transfer addressing pain and poor prosthetic fit at amputation sites.
What is the current status of trial NCT02076022?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2014-04-08. Estimated completion is 2019-01-28.
What conditions does trial NCT02076022 study?
This clinical trial studies the following conditions: Amputation, Wounded Warrior, Limb Shortening.
What interventions are being tested in trial NCT02076022?
The interventions under investigation include: Enhanced Fat Grafting (DEVICE), Standard fat graft (PROCEDURE).
Who is sponsoring clinical trial NCT02076022?
This trial is sponsored by J. Peter Rubin, MD, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02076022 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amputation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02076022's enrollment target sits among peer trials
10 50th of 65 higher than 15 of 65 other Amputation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Amputation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Myoelectric Implantable Recording Array (MIRA) in Participants With Transradial Amputation
RECRUITING · NA
-
Efficacy and Mechanisms of Virtual Reality Treatment of Phantom Leg Pain.Home-Based Treatment
RECRUITING · NA
-
Hand Transplantation
RECRUITING · NA
-
Target Muscle Re-innervation and Regenerative Peripheral Nerve Interfaces Alone and in Combination for the Treatment of Residual and Phantom Limb Pain in Cancer Patients Who Have Received an Amputation
RECRUITING · NA
-
Can an Array of Micro-electrodes Implanted in a Human Nerve Record Neural Signals and Provide Feedback?
RECRUITING · NA
-
Intuitive Control of a Hybrid Prosthetic Leg During Ambulation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI